NASDAQ:HALO - Halozyme Therapeutics, Inc.
$16.50
 $0.21
+1.29%
12:20PM EDT
2019-07-22
Halozyme Therapeutics, Inc. is a biotechnology company focused on developing and commercializing oncology therapies. The Company operates in research, development and commercialization of human enzymes and other drug candidates. The Company's segment also includes research and development activities and product sales of Hylenex recombinant. The Company's development pipeline consists of clinical-stage product candidates in oncology. Its lead oncology program is PEGPH20 (polyethylene glycol (PEG)ylated recombinant human hyaluronidase), a molecular entity being developed for the systemic treatment of tumors, which accumulate HA. It is in Phase II and Phase III clinical testing for PEGPH20 in stage IV pancreatic ductal adenocarcinoma (Studies 109-202 and 109-301); Phase Ib clinical testing in non-small cell lung cancer (Study 107-201), and in Phase Ib clinical testing in non-small cell lung cancer and gastric cancer (Study 107-101). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  HALO     avg for
industry  
  avg for
sector  
42 stocks weight:  90. 82   217. 37   399. 45  
42 stocks rank:  1. 84 K 1. 27 K 716. 99  
# analyst opinions:  9. 00   13. 21   13. 71  
mean recommendation:  2. 60   2. 10   2. 04  

quick ratio:  2. 57   5. 49   1. 88  
current ratio:  2. 95   5. 87   2. 36  

target price low:  10. 00   83. 44   114. 90  
target price avg:  20. 56   106. 20   137. 90  
target price high:  33. 00   132. 30   158. 97  
1-yr high:  18. 66   111. 86   142. 57  
last close:  16. 29   86. 79   125. 44  
50-day avg:  16. 13   86. 68   122. 63  
200-day avg:  16. 15   89. 22   121. 38  
1-yr low:  13. 33   69. 78   100. 51  
volume:  335. 06 K 2. 62 M 3. 43 M
50-day avg volume:  886. 42 K 3. 20 M 4. 16 M
200-day avg volume:  831. 29 K 2. 99 M 4. 75 M

1-day return:  -2. 98 % -1. 30 % -0. 99 %
this week return:  -1. 75 % 0. 45 % -0. 20 %
12-wk return:  0. 43 % 0. 94 % 4. 84 %
52-wk return:  -6. 89 % -1. 30 % 10. 55 %

enterprise value (EV):  2. 21 B 45. 10 B 122. 38 B
market cap:  2. 37 B 38. 96 B 108. 40 B
EBITDA:  -40. 24 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -54. 95   5. 38   11. 93  
enterprise/revenue (EV/R):  12. 43   57. 92   10. 21  
total revenue:  177. 94 M 9. 91 B 39. 98 B
total debt:  114. 20 M 10. 90 B 17. 48 B
debt/equity:  43. 92   57. 18   120. 05  
net income (common):  -51. 07 M 2. 07 B 4. 05 B

shares outstanding:  145. 51 M 538. 09 M 1. 24 B
shares:  132. 82 M 548. 00 M 1. 22 B
shares short:  7. 46 M 10. 98 M 11. 87 M
shares short prior month:  7. 58 M 9. 32 M 12. 05 M
short ratio:  7. 07   5. 60   3. 34  
short % of float:  5. 75 % 6. 48 % 2. 64 %
total cash/share:  2. 27   10. 98   9. 19  
total cash:  328. 72 M 5. 93 B 6. 10 B
free cash flow:  -18. 48 M 2. 92 B 4. 55 B
operating cash flow:  -31. 75 M 3. 80 B 5. 78 B

book value:  1. 80   13. 35   27. 45  
price/book:  9. 07   4. 60   8. 78  
gross profits:  -8. 53 M 7. 44 B 36. 13 B
operating margins:  -23. 97 % -308. 40 % -28. 55 %
EBITDA margins:  -22. 61 % 13. 17 % 23. 38 %
profit margins:  -28. 70 % 10. 44 % 14. 18 %
gross margins:  12. 70 % 35. 80 % 55. 40 %

1-yr max volatility:  9. 15 % --- ---
1-yr mean volatility:  1. 86 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 36   2. 10   4. 23  
forward EPS:  -0. 43   3. 45   7. 10  
P/E:  -45. 25   1. 90   32. 10  
forward P/E:  -39. 05   6. 46   15. 47  
PE/G:  -0. 54   0. 70   -0. 54  
growth:  84. 50 % 265. 63 % 79. 11 %
earnings high:  -0. 03   0. 89   1. 68  
earnings avg:  -0. 14   0. 70   1. 57  
earnings low:  -0. 22   0. 46   1. 46  
revenue high:  59. 00 M 2. 57 B 11. 07 B
revenue avg:  42. 76 M 2. 51 B 10. 91 B
revenue low:  32. 16 M 2. 45 B 10. 73 B
return on assets:  -5. 77 % -2. 34 % 5. 28 %
return on equity:  -19. 45 % -90. 08 % 133. 53 %
revenue growth:  84. 50 % 265. 25 % 73. 68 %
revenue/share:  1. 24   12. 72   60. 04  

beta (1yr vs S&P500):  1. 58   1. 27   0. 91  
sharpe (1yr):  -0. 09   0. 16   0. 77  

held % insiders:  8. 48 % 6. 06 % 3. 29 %
held % institutions:  0. 00 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : HALO
.    122.655 =       122.655 :: --> INITIAL WEIGHT <--
.     - 0.36 =       122.295 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.883 =       352.559 :: P/E factor
.    x 1.169 =       412.136 :: PE/G factor
.    x 1.658 =       683.441 :: beta factor
.    x 0.668 =       456.397 :: sharpe factor
.    x 2.503 =      1142.239 :: current ratio factor
.    x 1.279 =      1460.693 :: quick ratio factor
.    x 1.068 =       1560.58 :: short ratio factor
.    x 2.084 =       3252.49 :: revenue growth factor
.    x 1.215 =      3950.332 :: EV/R factor
.      x 1.1 =      4346.778 :: price-to-book factor
.    x 1.558 =      6772.748 :: debt-to-revenue factor
.     x 1.33 =       9005.47 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     19098.737 :: sector+industry 1-year gains factor
.    x 1.009 =     19278.802 :: industry 12-weeks return factor
.    x 1.308 =     25214.524 :: industry 2-weeks return factor
.    x 0.977 =     24637.015 :: company one-year gains+dividend factor
.    x 2.984 =      73520.83 :: company 13 weeks' performance factor
.    x 1.073 =     78911.312 :: 5-day avg > 200-day avg
.     x 1.16 =     91503.305 :: 5-day avg > 50-day avg
.    x 0.998 =     91293.956 :: "drift" penalty 1 days ago
.    x 0.984 =     89854.617 :: "drift" penalty 5 days ago
.    / 1.811 =     49628.537 :: overall "drift" factor
.    x 0.941 =     46703.093 :: largest single-day jump factor
.    x 0.993 =     46387.186 :: volatility factor
.    x 0.995 =     46152.564 :: 42-day volatility factor
.    x 3.067 =    141550.707 :: notable returns + performance factor
.    x 3.695 =    522988.539 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.185 =     96700.581 :: forward EPS factor
.    x 0.704 =     68058.718 :: forward P/E factor
.    x 1.185 =     80630.013 :: industry recommendation factor
.    x 1.694 =    136615.209 :: company recommendation factor
.    x 1.003 =    136993.003 :: factor historical industry gain for week 29
.    x 0.905 =    124001.071 :: target low factor
.    x 1.171 =    145163.113 :: target mean factor
.    x 1.043 =     151338.06 :: target high factor
.   x 10.191 =   1542333.685 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        35.241 :: reduced for readability
.   + 55.251 =        90.492 :: add/subtract for investor sentiment
.     + 0.33 =        90.822 :: earnings report in 15 days
.                               --> FINAL WEIGHT <--
.                     90.822 :: FINAL WEIGHT for NASDAQ:HALO


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org